Abstract
AimsEpidermal growth factor receptor (EGFR) T790M mutations can be detected in the circulating tumour DNA from plasma of patients with non-small cell lung cancer (NSCLC) to triage patients for osimertinib...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have